| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/14/2011 | CA2475534C Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 06/14/2011 | CA2468704C Urea derivatives as angiogenesis inhibitors |
| 06/14/2011 | CA2458267C Bifunctional chelating agent for actinium |
| 06/14/2011 | CA2452752C Dye-azide compounds for dual phototherapy |
| 06/14/2011 | CA2446260C Novel expression vectors and uses thereof |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2425311C Ketone compounds and compositions for cholesterol management and related uses |
| 06/14/2011 | CA2413313C Antitumor effect potentiators |
| 06/14/2011 | CA2400888C Bifunctional chelating agent |
| 06/14/2011 | CA2369622C Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 06/14/2011 | CA2365416C Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 06/14/2011 | CA2337205C Treatment of skin disorders |
| 06/14/2011 | CA2301327C Use of herpes vectors for tumor therapy |
| 06/14/2011 | CA2293829C Methods and compositions for galactosylated glycoproteins |
| 06/09/2011 | WO2011069149A2 Cathepsin s inhibitors |
| 06/09/2011 | WO2011069141A2 Interferon therapies in combination with blockade of stat3 activation |
| 06/09/2011 | WO2011069118A1 Ship1 modulators and methods related thereto |
| 06/09/2011 | WO2011069053A1 Process for the preparation of pazopanip hcl and crystalline forms of pazopanib hcl |
| 06/09/2011 | WO2011069045A2 Synthesis of syrbactin proteasome inhibitors |
| 06/09/2011 | WO2011069039A1 Hydrazone and diacyl hydrazine compounds and methods of use |
| 06/09/2011 | WO2011068978A1 Methanocarba adenosine derivatives and dendrimer conjugates thereof |
| 06/09/2011 | WO2011068934A2 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods |
| 06/09/2011 | WO2011068894A2 Novel curcumin-antibody conjugates as anti-cancer agents |
| 06/09/2011 | WO2011068863A1 Combination therapy for treating cancer and diagnostic assays for use therein |
| 06/09/2011 | WO2011068561A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/09/2011 | WO2011068546A2 Prognosis, diagnosis and identification of multiple myeloma based on global gene expression profiling |
| 06/09/2011 | WO2011068403A2 Novel n-{3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamjne salts |
| 06/09/2011 | WO2011068386A2 Anticancer composition containing a kampheride compound as an active ingredient |
| 06/09/2011 | WO2011068226A1 Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages |
| 06/09/2011 | WO2011068187A1 Quinazoline derivatives |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011067933A1 Mybl2 peptides and vaccines containing the same |
| 06/09/2011 | WO2011067920A1 Imp-3 oligopeptides and vaccines including the same |
| 06/09/2011 | WO2011067185A1 Spiroindolinone pyrrolidines |
| 06/09/2011 | WO2011067161A1 Prostate cancer dna vaccine |
| 06/09/2011 | WO2011066783A1 Anti-cyr61 protein monoclonal antibodies and uses thereof |
| 06/09/2011 | WO2011066684A1 Liposome of irinotecan or its hydrochloride and preparation method thereof |
| 06/09/2011 | WO2011066681A1 Human high metastatic nasopharyngeal carcinoma cell strain s18 stably expressing tet-off advanced, construction method and uses thereof |
| 06/09/2011 | WO2011066606A1 Pyranoindole compounds and uses thereof |
| 06/09/2011 | WO2011041596A3 19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring |
| 06/09/2011 | WO2011019634A3 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 06/09/2011 | WO2011014661A3 Liver x receptor agonists |
| 06/09/2011 | WO2011009826A3 Novel chalcone derivatives with cytotoxic activity |
| 06/09/2011 | US20110138491 Compositions and Method for Epigenetic Modification of Nucleic Acid Sequences in Vivo |
| 06/09/2011 | US20110137285 Kit of tamponing liquids and a method for the treatment of tears and/or detachments of the retina using such liquids |
| 06/09/2011 | US20110137235 Ultrasonic cancer therapy accelerator |
| 06/09/2011 | US20110136922 Activation induced deaminase (aid) |
| 06/09/2011 | US20110136916 6-shogaol for using in a method for the treatment of leukemia |
| 06/09/2011 | US20110136913 Assessing and treating breast cancer patients |
| 06/09/2011 | US20110136906 Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 06/09/2011 | US20110136905 Crystalline teglicar |
| 06/09/2011 | US20110136902 12-membered-ring macrolactam derivatives |
| 06/09/2011 | US20110136895 Methods and compositions for modulating PD1 |
| 06/09/2011 | US20110136894 Shortened Alk1 Regulatory Fragment |
| 06/09/2011 | US20110136893 Oligonucleotide-, protein and/or peptide-polymer conjugates |
| 06/09/2011 | US20110136891 Nucleic acid molecules and collections thereof, their application and Identification |
| 06/09/2011 | US20110136888 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 06/09/2011 | US20110136887 Heterocyclic Amide Derivatives as EP4 Receptor Antagonists |
| 06/09/2011 | US20110136880 Latrunculin-Based Macrolides and Their Uses |
| 06/09/2011 | US20110136873 Inhibitors of Cyclin Dependent Kinases and Their Use |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136868 Agents for inhibiting osteoclastogenesis and/or osteoclast activation |
| 06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
| 06/09/2011 | US20110136856 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 06/09/2011 | US20110136850 Methods and compositions for topoisomerase i modulated tumor suppression |
| 06/09/2011 | US20110136841 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 06/09/2011 | US20110136838 Chemical compounds |
| 06/09/2011 | US20110136834 Inhibitors of e1 activating enzymes |
| 06/09/2011 | US20110136830 Chromenone derivatives |
| 06/09/2011 | US20110136828 Substituted n-oxide pyrazine derivatives |
| 06/09/2011 | US20110136827 Bis-Acylated Hydroxylamine Derivatives |
| 06/09/2011 | US20110136826 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 06/09/2011 | US20110136819 6-thioxopyridazine derivatives |
| 06/09/2011 | US20110136813 Wnt protein signalling inhibitors |
| 06/09/2011 | US20110136812 Solubilized topoisomerase poisons |
| 06/09/2011 | US20110136810 Antitumor agent, kit and method of treating cancer |
| 06/09/2011 | US20110136809 Substituted Pyrazolyl Urea Derivatives Useful In The Treatment Of Cancer |
| 06/09/2011 | US20110136806 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof |
| 06/09/2011 | US20110136805 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 06/09/2011 | US20110136802 Ship1 modulators and methods related thereto |
| 06/09/2011 | US20110136801 Novel Compounds |
| 06/09/2011 | US20110136796 IDO Inhibitors |
| 06/09/2011 | US20110136789 C-met protein kinase inhibitors |
| 06/09/2011 | US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 06/09/2011 | US20110136781 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 06/09/2011 | US20110136773 Pharmaceutical Uses of Lanosta-8,24-dien-3-ols |
| 06/09/2011 | US20110136768 Imatinib mesylate for the treatment of nephrogenic systemic fibrosis |
| 06/09/2011 | US20110136766 Aurora kinase inhibitors |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110136764 Amino pyrimidine anticancer compounds |
| 06/09/2011 | US20110136760 Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and other Proliferative Diseases |
| 06/09/2011 | US20110136756 Combination antitumor therapy |
| 06/09/2011 | US20110136754 Novel triazole derivatives, their preparation and their application in therapeutics |
| 06/09/2011 | US20110136753 Glycosylated indolecarbazoles, method for obtaining same and uses thereof |
| 06/09/2011 | US20110136751 Use of Polyphenols in the Treatment of Cancer |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136741 Dicarba-analogues of octreotide |
| 06/09/2011 | US20110136728 Methods of increasing bone formation using leptin-related peptides |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |